Dive Into Other Topics

Jun 19, 2026

Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...

May 08, 2026

Summary BTC (including cholangiocarcinoma and gallbladder cancer) is a challenging malignancy with rising global incidence, especially in Asia and Latin America, driven by risk factors like chronic inflammation and liver flukes; ~65,000 incident cases in 7MM in 2025, projected to grow by 2036, with highest case...

Aug 27, 2025

The global healthcare landscape is witnessing a seismic shift, propelled by the rapid integration of smart healthcare technology into everyday medical practice. At the forefront of this transformation are smart medical devices are intelligent tools that combine advanced sensors, wireless connectivity, data analytic...

Aug 22, 2025

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.

Jul 10, 2025

Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.

Jul 01, 2025

Although there has been tremendous investment in chronic spontaneous urticaria treatment, there are still gray areas that require attention.

Jun 10, 2025

On 19 May 2023, FDA approved Abbvie-Genmab’s EPKINLY, as the first CD20XCD3 bispecific antibody R/R DLBCL treatment in adults.

Jun 06, 2025

Cloud computing in the healthcare industry is growing at an immense pace. Despite some difficulties, the advantages of cloud computing are more compared to disadvantages

Jun 06, 2025

As per the latest assessment by DelveInsight, the global sleep tech devices market was valued at ~USD 17 billion in 2023, growing at a CAGR of 17.31% during the forecast period from 2024 to 2030 to reach ~USD 44 billion by 2030.

Mar 14, 2025

80+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.